Rapid progression of a walking disability in a 5-year-old boy with a CLN6 mutation

• Published in: Brain & development (Tokyo. 1979) Vol. 41; no. 8; pp. 726 - 730
• Main Authors: Matsumoto, Ayumi, Nagashima, Masako, Iwama, Kazuhiro, Mizuguchi, Takeshi, Makino, Shinji, Ikeda, Takahiro, Muramatsu, Kazuhiro, Matsumoto, Naomichi, Yamagata, Takanori, Osaka, Hitoshi
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.09.2019
• Subjects: Child, Preschool; CNL6; Disease Progression; Epilepsy - genetics; Homozygote; Humans; Japan; Male; Membrane Proteins - genetics; Membrane Proteins - metabolism; Mobility Limitation; Mutation; Neuronal ceroid lipofuscinoses (NCL); Neuronal Ceroid-Lipofuscinoses - genetics; Neuronal Ceroid-Lipofuscinoses - metabolism; Regression; Seizures - genetics; Walking - physiology; Japan; Regression; CNL6; Neuronal ceroid lipofuscinoses (NCL)
• ISSN: 0387-7604; 1872-7131
• DOI: 10.1016/j.braindev.2019.04.009

Neuronal ceroid lipofuscinoses (NCLs; CLN) are mainly autosomal recessive neurodegenerative disorders characterized by the accumulation of autofluorescent lipopigments in neuronal and other cells. Symptoms include visual disabilities, motor decline, and epilepsy. Causative genes are CLN1, CLN2, CLN3, CLN5, CLN6, CLN7, CLN8, CLN10, CLN11, CLN12, CLN13, and CLN14. We present the fourth Japanese case with a CLN6 mutation. At 3 years of age, our patient became clumsy and fell down easily. He developed focal seizures with impaired consciousness and was started on carbamazepine. He showed ataxic walking and dysarthria with increased deep tendon reflexes. Interictal electroencephalogram revealed slow waves in the left temporal and occipital areas. Brain magnetic resonance imaging showed cerebellar atrophy and ventriculomegaly. In optical coherence tomography (OCT), the inner layer of the retina was thick and highly reflective. Exome sequencing revealed a known homozygous mutation, C.794_976del, p. (Ser265del) in CLN6. A total of 130 cases of NCL with CLN6 mutations have been reported globally, of which only four were from Japan including the current patient. The deletion of serine at position 265 has been reported in six cases. Ser265 is located in a region of short repeated sequences that is susceptible to mutation. Clinical trials of gene therapy using adeno-associated virus serotype 9 have started for NCL6, making early diagnosis crucial. OCT examination might be helpful in achieving a diagnosis.